LMICs’ R&D Funding For Neglected Diseases Remains Low, Report Says

“Developing nations’ research and development (R&D) funding for neglected diseases remains low, despite hopes that emerging economies would provide new funding streams, according to a major annual report published [Wednesday],” SciDev.Net reports. “Low- and middle-income countries (LMICs) provided only four percent of public funding for such R&D in 2012, the sixth ‘G-FINDER’ (Global Funding of Innovation for Neglected Diseases) report shows,” the news service writes. “The report also found that more than 99 percent of LMIC funding is directed at domestic research, rather than regional or international research efforts,” SciDev.Net writes, adding, “This shows that these countries prioritize growing their domestic research capacity over global health priorities, it says” (Kennedy, 12/11).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.